CRL
Charles River Laboratories
281.70$
+3.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.6% | 61.0% | 61.7% | 62.3% | 62.9% | 63.4% | 63.3% | 62.3% | 63.2% | 63.6% | 67.1% | 69.5% | |
| 36.4% | 39.0% | 38.3% | 37.7% | 37.1% | 36.6% | 36.7% | 37.7% | 36.8% | 36.4% | 32.9% | 30.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 20.3% | 20.7% | 21.9% | 19.6% | 18.5% | 18.5% | 18.1% | 17.5% | 16.7% | 18.2% | 18.5% | 18.0% | |
| 22.7% | 23.8% | 24.2% | 22.2% | 22.4% | 23.2% | 21.9% | 21.0% | 20.4% | 21.4% | 27.3% | 17.9% | |
| 13.7% | 15.1% | 14.1% | 15.5% | 14.6% | 13.4% | 14.8% | 16.7% | 16.4% | 14.9% | 5.6% | 12.6% | |
| 0.9% | 1.1% | 1.6% | 1.6% | 2.8% | 2.3% | 3.0% | 2.1% | 1.5% | 3.3% | 3.1% | 2.7% | |
| 13.7% | 14.3% | 13.3% | 16.0% | 12.4% | 11.6% | 15.3% | 13.6% | 15.7% | 14.1% | 2.3% | -2.5% | |
| 3.7% | 3.2% | 4.0% | 9.2% | 2.4% | 1.9% | 2.8% | 2.3% | 3.3% | 2.4% | 1.7% | 1.1% | |
| 9.8% | 11.0% | 9.2% | 6.6% | 10.0% | 9.6% | 12.5% | 11.0% | 12.2% | 11.5% | 0.3% | -3.6% | |
| 22.0% | 22.4% | 22.4% | 24.6% | 22.4% | 21.5% | 26.3% | 23.2% | 24.8% | 25.0% | 14.3% | 10.2% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.